Gentian Diagnostics ASA (OSL:GENT)

Norway flag Norway · Delayed Price · Currency is NOK
52.80
-0.40 (-0.75%)
Oct 24, 2025, 2:59 PM CET
-0.75%
Market Cap820.47M
Revenue (ttm)172.52M
Net Income (ttm)42.78M
Shares Out15.42M
EPS (ttm)2.74
PE Ratio19.41
Forward PE33.01
Dividend0.40 (0.75%)
Ex-Dividend DateMay 7, 2025
Volume7,730
Average Volume17,777
Open53.00
Previous Close53.20
Day's Range52.00 - 53.00
52-Week Range37.00 - 65.80
Beta0.22
RSI41.79
Earnings DateOct 23, 2025

About Gentian Diagnostics ASA

Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe. The company offers in-vitro diagnostic reagents for clinical chemistry analyzers, such as Gentian Circulating Calprotectin Immunoassay, a turbidimetric assay used for the measurement of calprotectin in plasma and serum for detection and assessment of inflammation; Gentian Cystatin C Immunoassay test kit, a GFR marker for the diagnosis and therapeutic control of renal function and chro... [Read more]

Sector Healthcare
Founded 2001
Employees 63
Stock Exchange Oslo Børs
Ticker Symbol GENT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.